Hybrid polypeptides with selectable properties

Details for Australian Patent Application No. 2005211755 (hide)

Owner Amylin Pharmaceuticals, Inc.

Inventors Mack, Christine M.; Jodka, Carolyn M.; D'Souza, Lawrence J.; Levy, Odile Esther; Ghosh, Soumitra S.; Hanley, Michael R.; Soares, Christopher J.; Lewis, Diana Y.; Parkes, David G.

Agent Freehills

Pub. Number AU-B-2005211755

PCT Pub. Number WO2005/077072

Priority 60/543,407 11.02.04 US

Filing date 11 February 2005

Wipo publication date 25 August 2005

Acceptance publication date 15 March 2012

International Classifications

C07K 14/575 (2006.01) Peptides having more than 20 amino acids

C07K 14/595 (2006.01) Peptides having more than 20 amino acids

Event Publications

24 August 2006 PCT application entered the National Phase

  PCT publication WO2005/077072 Priority application(s): WO2005/077072

15 March 2012 Application Accepted

  Published as AU-B-2005211755

12 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005211759-System and method for product sterilization using UV light source

2005211754-Therapeutic and diagnostic conjugates for use with multispecific antibodies